KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in IntangiblesChange in IntangiblesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Cash from Financing Activities (2018 - 2026)

Astrazeneca has reported Cash from Financing Activities over the past 16 years, most recently at $267.0 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 109.86% year-over-year to $267.0 million; the TTM value through Mar 2026 reached -$4.6 billion, up 47.66%, while the annual FY2025 figure was -$7.5 billion, 88.79% down from the prior year.
  • Cash from Financing Activities for Q1 2026 was $267.0 million at Astrazeneca, up from -$3.3 billion in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $2.0 billion in Q1 2024 and troughed at -$6.5 billion in Q4 2022.
  • A 5-year average of -$1.9 billion and a median of -$1.8 billion in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: crashed 515.13% in 2022 and later skyrocketed 199.85% in 2024.
  • Year by year, Cash from Financing Activities stood at -$6.5 billion in 2022, then skyrocketed by 76.5% to -$1.5 billion in 2023, then surged by 55.83% to -$671.0 million in 2024, then tumbled by 389.12% to -$3.3 billion in 2025, then soared by 108.14% to $267.0 million in 2026.
  • Business Quant data shows Cash from Financing Activities for AZN at $267.0 million in Q1 2026, -$3.3 billion in Q4 2025, and -$2.1 billion in Q3 2025.